A 38-year-old man was diagnosed with HIV infection 1 year ago. Three months after the diagnosis, he complained of blurring vision in the left eye with floaters. The patient's vision was 6/9, and the fundoscopy image is shown in Figure 1 . Further, the patient had no other AIDS-defining illnesses. 
DISCUSSION
Cytomegalovirus retinitis (CMVR) remains one of the most common opportunistic ocular infections in patients with AIDS. This disease occurs in HIV-positive patients with profound immunosuppression, i.e., patients with a CD4 T-lymphocyte count of ≤50 cells/mm 3 .
[ [1] [2] [3] Although advances in antiretroviral therapy (ART) such as highly active ART (HAART) have significantly reduced the incidence of this disease, active CMVR in patients with higher T-cell counts can occur through the deletion of CMV-specific CD4 memory cells or blunted T-cell response. [1] [2] [3] [4] HAART is a combination of two nucleoside reverse transcriptase inhibitors and at least one protease inhibitor or nonnucleoside reverse transcriptase inhibitor. The combination has proven to significantly reduce the number of plasma HIV messenger RNA copies and to increase the number of CD4+ T lymphocytes. Since the introduction of HAART, the incidence of CMVR has declined by 50-80%. [4, 5] The strongest predictor for CMVR in the pre-HAART era was the absolute CD4 count, and the risk was directly correlated with lower CD4 counts. [1] [2] [3] [4] Most of the cases start as an unilateral retinal necrosis, and later, if left untreated, the second eye can be involved. 
Diagnosis
The most common clinical presentation is typical retinal necrosis with retinal hemorrhage progressing along the major retinal vessels emerging from the optic nerve. Further, the hemorrhages are more prominent than necrosis, CMVR can be differentiated from other retinal necrosis-causing diseases such as herpes retinitis.
During the early stages, the disease can start as multiple soft retinal exudate (cotton wool spots) with retinal hemorrhage and with minimal ocular symptoms.
In atypical cases, virtuous fluid is needed for polymerase chain reaction to reconfirm the diagnosis. [4, 5] 
Treatment
There are several antiviral medications that minimize the effects of CMVR such as ganciclovir, valganciclovir, foscarnet and cidofovir. The sooner the treatment is started, the better is the chance of improving the vision. In addition, if only one eye is infected, receiving proper systemic treatment early may protect the other eye.
Oral, intraocular (intravitreal) or intravenous medication are used to slow the progression of the disease, and the dose should be evaluated on a weekly basis.
